Identifying Methylation Biomarkers for Monitoring Bladder Tumors

Using PCR Technology (Polymerase Chain Reaction Technology) for Monitoring Patients With Bladder Tumors - Optimizing Genanalyses for Clinical Use.

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00244205

Enrollment

120

Registered

2005-10-26

Start date

2005-11-30

Completion date

Unknown

Last updated

2005-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder Cancer

Brief summary

To investigate the methylation status of 4-6 genes in Urine and matching bladder tissue biopsies, in order to find methylation markers for use in a noninvasive test in monitoring patients with bladder tumors.

Interventions

PROCEDUREIdentifying genes methylated in urine

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients with bladder tumors and patients with benign urinary tract conditions with no clinical suspicion of bladder cancer.

Exclusion criteria

* Patients with competing urinary and systemic diseases, pregnant and patients under 18 years of age.

Countries

Denmark

Contacts

Primary ContactReza R Serizawa, MD

rerase01@herlevhosp.kbhamt.dk+45 44884787

Backup ContactJørgen H Andersen

johvan01@herlevhosp.kbhamt.dk

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026